Frankfurt, Germany

Sabrina Ruggeberg

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Sanofi. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sabrina Ruggeberg. Retrieved from https://idiyas.com/inventor/sabrina-ruggeberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Sabrina Ruggeberg

Introduction

Sabrina Ruggeberg is an accomplished inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on stable IgG4 based binding agent formulations. With a total of 2 patents to her name, her work has the potential to impact the treatment of chronic bowel diseases and rheumatoid arthritis.

Latest Patents

Sabrina's latest patents include innovative formulations that provide stable pharmaceutical antibody solutions. These formulations consist of an IgG4 binding agent and a citrate buffer, with a pH at or below both pH 6 and the isoelectric point (pI) of the binding agent. The applications of these formulations are particularly relevant in treating chronic bowel diseases and rheumatoid arthritis, showcasing her commitment to advancing medical science.

Career Highlights

Sabrina is currently employed at Sanofi, a leading global healthcare company. Her role at Sanofi allows her to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Some of her notable coworkers include Julia Schnieders and Dirk Usener, who work alongside her in the pursuit of innovative solutions in healthcare.

Conclusion

Sabrina Ruggeberg's contributions to pharmaceutical formulations exemplify her dedication to improving patient care through innovation. Her work continues to pave the way for advancements in the treatment of chronic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…